Nosocomial legionellosis: Prevention and management

Expert Review of Anti-Infective Therapy

Volumn 7, Issue 1, 2009, Pages 57-68

  Levin, Anna S ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Diagnosis; Legionnaires' disease; Nosocomial pneumonia; Prevention; Treatment

Indexed keywords

ANTIINFECTIVE AGENT; AZITHROMYCIN; CHLORINE DIOXIDE; CIPROFLOXACIN; CLARITHROMYCIN; COPPER; DEFORMYLASE INHIBITOR; DOXYCYCLINE; ERYTHROMYCIN; LEVOFLOXACIN; MACROLIDE; MONOCHLORAMINE; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SILVER; UNCLASSIFIED DRUG;

BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM CONTAMINATION; CHLORINATION; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DISINFECTION; DRUG EFFICACY; DRUG TOLERABILITY; ENGINEERING; ENVIRONMENTAL MANAGEMENT; EPIDEMIC; ERADICATION THERAPY; HABITAT; HEATING; HIGH RISK POPULATION; HIGH TEMPERATURE; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INFECTION RISK; IONIZATION; IRRADIATION; LABORATORY DIAGNOSIS; LEGIONELLA; LEGIONNAIRE DISEASE; MICROBIAL ACTIVITY; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; NONHUMAN; OZONATION; PREVENTIVE HEALTH SERVICE; REVIEW; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE; ULTRAVIOLET RADIATION; UNSPECIFIED SIDE EFFECT; WATER CONTAMINATION; WATER SUPPLY; WATER TREATMENT;

EID: 69449100113     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/14787210.7.1.57     Document Type: Review

References (89)

1. Fraser DW. The challenges were legion. Lancet Infect. Dis. 5, 237-241 (2005).
2. Fields BS, Benson RF, Besser RE. Legionella and Legionnaire's disease: 25 years of investigation. Clin. Microbiol. Rev. 15, 506-526 (2002).
3. Yu VL, Plouffe JF, Castellani Pastoris MC et al. Distribution of Legionella species and serogroups isolated by culture in patients with sporadic community-acquired legionellosis: an international collaborative survey. J. Infect. Dis. 186, 127-128 (2002).
4. Lück PC. Diagnostics and clinical disease treatment. In: Legionella? Molecular Microbiology. Heuner K and Swanson M (Eds). Caister Academic Press, Norfolk, UK 19-34 (2008).
5. Liang JL, Dziuban EJ, Craun GF et al. Surveillance for waterborne disease and outbreaks associated with drinking water and water not intended for drinking - US, 2003-2004. MMWR Surveill. Summ. 55(12), 31-58 (2006).
6. Weir R. Coping with Legionella. CAMJ 163, 1336 (2000).
7. Sabrià M, Yu VL. Hospital-acquired legionellosis: solutions for a preventable infection. Lancet Infect. Dis. 2, 368-373 (2002).
8. Lasheras A, Boulestreau H, Rogues AM et al. Influence of amoebae and physical and chemical characteristics of water on the presence and proliferation of Legionella species in hospital water systems. Am. J. Infect. Control 34, 520-525 (2006).
9. Patterson WJ, Hay J, Seal DV et al. Colonization of transplant unit water supplies with Legionella and protozoa: precautions required to reduce the risk of legionellosis. J. Hosp. Infect. 37, 7-17 (1997).
10. Goh KT, Ng DLK, Yap J, Ma S, Ooi EE. Surveillance, prevention, and control of legionellosis in a tropical city-state. Am. J. Infect. Control 33, 286-291 (2005).
11. Fraser DW, Tsai TR, Orenstein W et al. Legionnaires' disease. N. Engl. J. Med. 297, 1189-1197 (1977).
12. Smith P, Moore M, Alexander N et al., Hicks L, O'Loughlin R. Surveillance for travel-associated Legionnaire's Disease - US, 2005-2006. MMWR 56(48), 1261-1263 (2007).
13. Leoni E, De Luca G, Legnani PP, Sacchetti R, Stampi S, Zanetti F. Legionella waterline colonization: detection of Legionella species in domestic, hotel and hospital hot water systems. J. Appl. Microbiol. 98, 373-379 (2005).
14. Borella P, Montagna MT, Romano-Spica V et al. Legionella infection risk from domestic hot water. Emerg. Infect. Dis. 10, 457-464 (2004).
15. Rangel-Fausto MS, Rhomberg P, Hollis RJ et al. Persistence of Legionella pneumophila in a hospital's water system: a 13-year survey. Infect. Control Hosp. Epidemiol. 20, 793-797 (1999).
16. Kool JL, Bergmire-Sweat D, Butler JC et al. Hospital characteristics associated with colonization of water systems by Legionella and risk of nosocomial Legionnaire's diseases: a cohort study of 15 hospitals. Infect. Control Hosp. Epidemiol. 20, 798-805 (1999).
17. Yu VL, Zuravleff J, Gavlik L, Magnussen MH. Lack of evidence for pcrson-to-person transmission of Legionnaires' disease. J. Infect. Dis. 147, 362 (1983).
18. Dpndero TJ, Rentorff RC, Mallison GF et al. An outbreak of Legionnaires' disease associated with a contaminated air-conditioning cooling tower. N. Engl. J. Med. 302, 365-370 (1980).
19. Garbe PL, Davis BJ, Weisfeld JS et al. Nosocomial Legionnaires' disease - epidemiologic demonstration of cooling towers as a source. JAMA 254, 521-524 (1985).
20. Tobin JO, Bea're J, Dunnill MS et al. Legionnaires' disease in a transplant unit: isolation of the causative agent from shower baths. Lancet 316, 118-121 (1980).
21. Arnow PM, Chou T, Weil D, Shapiro EN, Kretzschmar C. Nosocomial Legionnaires' disease caused by aerosolized tap water from respiratory devices. J. Infect. Dis. 146, 4607 (1982).
22. Woo AH, Goetz A, Yu VL. Transmission of Legionella by respiratory equipment and aerosol generating devices. Chest 102, 1586-1590 (1992).
23. Levin AS, Caiaffa Filho HH, Sinto SI, Sabbaga E, Barone AA, Mendes CMF. An outbreak of nosocomial Legionnaires' disease in a renal transplant unit in São Paulo, Brazil. J. Hosp. Infect. 18, 243-248 (1991).
24. Breiman RF, Fields BS, Sanden GN, Volmer L, Meier A, Spika JS. Association of shower use with Legionnaires' disease - possible role of amoebae. JAMA 263, 2924-2926 (1990).
25. Muder RR, Yu VL, Woo AH. Mode of transmission of Legionella pneumophila. Arch. Intern. Med. 146, 1607-1612 (1986).
26. Woo AH, Yu VL, Goetz A. Potential in-hospital modes of transmission of Legionella pneumophila. Am. J. Med. 80, 567-573 (1986).
27. Yu VL. Could aspiration be the major mode of transmission for Legionella? Am. J. Med. 95, 13-15 (1993).
28. Hosein IK, Hill DW, Tan TY et al. Point-of-care controls for nosocomial legionellosis combined with chlorine dioxide potable water decontamination: a two-year survey at a Welsh teaching hospital. J. Hosp. Infect. 61, 100-106 (2005).
29. Muder RR, Stout JE, Yee YC. Isolation of Legionella pneumophila serogroup 5 from empyema following esophageal perforation. Chest 102, 1601-1602 (1992).
30. Lee JV, Joseph C; on behalf of the PHLS Atypical Pneumonia Working Group. Guidelines for investigating single cases of Legionnaires disease. Commun. Dis. Public Health 5, 157-162 (2002).
31. Sehulster L, Chinn RY. Guidelines for eryyironmental infection control in health-care facilities. MMWR Recomm. Ref. 52(10), 1-42 (2003).
32. Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R. Guidelines for preventing health-care-associated pneumonia, 2003. MMWR Recomm. Ref. 53(3), 1-36 (2004).
33. Fallon RJ. How to prevent an outbreak of Legionnaires' disease. J. Hosp. Infect. 27, 247-256 (1994).
34. Hart CA, Makin T. Legianella in hospitals: a review. J. Hosp. Infect. 18, 481-489 (1991).
35. States S, Yee RB, Conley LF. Legionella Bacteria in Potable Water Systems - A Position Paper. Canadian Electrical Association, Montreal, Quebec, Canada (1990).
36. Darelid J, Löfgren S, Malmvall BE. Control of nosocomial Legionnaire's disease by keeping the circulating hot water temperature above 55°C: experience from a 10-year surveillance programme in a district general hospital. J. Hosp. Infect. 50, 213-219 (2002).
37. Callizo EFP, Sierra JD, Pombo JMS, Baquedano CE, Huerta BP. Evaluation of the effectiveness of the Pastormaster method for disinfection of Legionella in a hospital water distribution system. J. Hosp. Infect. 60, 150-158 (2005).
38. Levin AS, Gobara S, Scarpitta CM et al. Electric showers as a control measure for Legionella spp in a renal transplant unit in São Paulo, Brazil. J. Hosp. Infect. 30, 133-137 (1995).
39. Chen YS, Liu YC, Lee SSJ et al. Abbreviated duration of superheat-and-flush and disinfection of raps for Legionella disinfection: lessons learned from failure. Am. J. Infect. Controls, 606-610 (2005).
40. Moutchtouri V, Velonakis E, Hadjichristodoulou C. Thermal disinfection of hotels, hospitals, and athletic venues hot water distribution systems contaminated by Legionella specieis. Am. J. Infect. Control 35, 623-627 (2007).
41. Oliveira MS, Maximino FR, Lobo RD et al. Disconnecting central hot water and using electric showers to avoid colonization of the water system by Legionella pneumophila: an 11-year study. J. Hosp. Infect. 66, 327-331 (2007).
42. Kim BR, Anderson JE, Mueller SA, Gaines WA, Kendall AM. Literature review-efficacy of various disinfectants against Legionella in water systems. Water Res. 36, 4433-4444 (2002).
43. Srinivasan A, Bova G, Ross T et al. A 17-month evaluation of a chlorine dioxide water treatment system to control Legionella species in a hospital water supply. Infect. Control Hosp. Epidemiol. 24, 575-579 (2003).
44. Zhang Z, McCann C, Stout JE et al. Safety and efficacy of chlorine dioxide for Legionella control in a hospital water system. Infect. Control Hosp. Epidemiol. 28, 1009-1012 (2007).
45. Kool JL, Carpenter JC, Fields BS. Effect of monochloramine disinfection of municipal drinking water on the risk of nosocomial Legionnaire's disease. Lancet 353, 272-277 (1999).
46. Flannery B, Gelling LB, Vugia DJ et al. Reducing Legionella colonization of water systems with monochloramine. Ernerg. Infect. Dis. 12, 588-596 (2006).
47. Moore MR, Pryor M, Fields B, Lucas C, Phelan M, Besser RE. Introduction of monochloramine into a municipal water system: impact on colonization of buildings by Legionella spp. Appl. Environ. Microbiol. 72, 378-383 (2006).
48. Cachafeiro SP, Naveira IM, García IG. Is copper-silver ionization safe and effective in controlling Legionella? J. Hosp. Infect. 67, 209-216 (2007).
49. Liu Z, Stout JE, Tedesco L et al. Controlled evaluation of copper-silver ionization in eradicating Legionella pneumophila from a hospital water distribution system. J. Hosp. Infect. 169, 919-922 (1994).
50. Biurrun A, Caballero L, Pelaz C, León E, Gago A. Treatment of a Legionella pneumophila-colonized water distribution system using copper-silver ionization and continuous chlorination. Infect. Control Hosp. Epidemiol. 20, 426-428 (1999).
51. Mòdol J, Sabrià M, Reynaga E et al. Hospital-acquired Legionnaires disease in a university hospital: impact of a copper-silver ionization system. Clin. Infect. Dis. 44, 263-265 (2007).
52. Franzin L, Cabodi D, Fantino C. Evaluation of the efficacy of ultraviolet irradiation for disinfection of hospital water contaminated by Legionella. J. Hosp. Infect. 51, 269-274 (2002).
53. Hall KK, Giannetta ET, Getchell-White SI, Durbin LJ, Farr BM. Ultraviolet light didinfection of hospital water for preventing nosocomial Legionella infection: a 13-year follow-up. Infect. Control Hosp. Epidemiol. 24, 580-583 (2003).
54. Triassi M, Di Poppolo A, D'Alcalà GR et al. Clinical and environmental distribution of Legionella pneumophila in a university hospital in Italy: efficacy of ultraviolet disinfection. J. Hosp. Infect. 62, 494-501 (2006).
55. Vonberg RP, Eckmanns T, Bruderek J, Rüden H, Gastmeier P. Use of terminal tap water filter systems for prevention of nosocomial legionellosis. J. Hosp. Infect. 60, 159-162 (2005).
56. Sheffer PJ, Stout JE, Wagener MM, Muder RR. Efficacy of new point-of-use water filter for preventing exposure to Legionella and waterborne bacteria. Am. J. Infect. Control 33(5 Suppl. 1), S20-S25 (2005).
57. Blanc DS, Carrara Ph, Zanetti G, Francioli P. Water disinfection with ozone, copper and silver ions, and temperature increase to control Legionella: seven years of experience in a university teaching hospital. J. Hosp. Infect. 60, 69-72 (2005).
58. Ditommaso S, Biasin C, Giacomuzzi M, Zotti CM, Cavanna A. Mairaghi AR. Peracetic acid in the disinfection of a hospital water system comtamianted with Legionella species. Infect. Control Hosp. Epidemiol. 26, 490-493 (2005).
59. Garcia MT, Pelaz C. Effectiveness of disinfectants used in cooling towers against Legionella pneumophila. Chemotherapy 54, 107-116 (2008).
60. O'Neill E, Humphreys H. Surveillance of hospital water and primary prevention of nosocomiai legionellosis: what is the evidence? J. Hosp. Infect. 59, 273-279 (2005).
61. Boccia S, Laurenti P, Borella P et al. Prospective 3-year surveillance for nosocomial and environmental Legionella pneumophila: implications for infection control. Infect. Control Hosp. Epidemiol. 27, 459-465 (2006).
62. Stout JE, Muder RR, Mietzner S et al. Role of environmental surveillance in determining the risk of hospital-acquired legionellosis: a national surveillance study with clinical correlations. Infect. Control Hosp. Epidemiol. 28, 818-824 (2007).
63. Mykietiuk A, Carratalá J, Fernández-Sabé N et al. Clinical outcomes for hospitalized patients with Legionella pneumonia in the antigenuria era: influence of levofloxacin therapy. Clin. Infect. Dis. 40, 794-799 (2005).
64. Bernstein JM. Treatment of community-acquired pneumonia - IDSA guidelines. Chest 115, 9-13 (1999).
65. Murdoch DR. Treating Legionnaires' disease. Intern. Med. J. 33, 479-481 (2003).
66. Dirven K, Ieven M, Peeters MF, van der Zee A, De Schrijver K, Goossens H. Comparison of three Legionella urinary antigen assays during an outbreak of legionellosis in Belgium. J. Med. Microbiol. 54, 1213-1216 (2005).
67. Lück PC, Helbig JH, von Baum H, Marre R. Diagnostics and clinical disease treatemtn: usefulness of microbiological, diagnostic methods for detection of Legionella infections. In: Legionella: State of the Art 30 Years After its Recognition. Cianciotto NP, Kwaik VA, Edelstein PH et al. (Eds). ASM Press, Washington, DC, USA 15-21 (2006).
68. Garbino J, Bornand J-E, Uçkay I, Fonseca S, Sax H. Impact of positive Legionella urinary antigen test on patient management and improvement of antibiotic use. J. Clin. Pathol. 57, 1302-1305 (2004).
69. Lindsay DSJ, Abraham WH, Findlay W, Christie P, Johnston F, Edwards GFS. Laboratory diagnosis of Legionnaires' disease due to Legionella pneumophila serogroup 1: comparison of phenotypic and genotypic methods. J. Med: Microbiol. 53, 183-187 (2004).
70. Diederen BMW, Kluytmans JAJW, Vandenbroucke-Grauls CM, Peeters MF. Utility of real-time PCR for diagnosis of Legionnaires' disease in routine clinical practice, J. Clin. Microbiol. 46, 671-677 (2008).
71. Edelstein PH. Antimicrobial chemotherapy for Legionnaires disease: time for a change. Ann. Intern. Med. 129, 328-330 (1998).
72. Edelstein PH. Legionnaires' disease: history and clinical findings. In: Legionella: Molecular Microbiology. Heuer K, Swanson M (Eds). Caister Academic Press, Norfolk, UK 1-17 (2008).
73. Birteksöz AS, Zeybek Z, Çotuk A. In vitro activities of various antibiotics againes Legionella pneumophila. In: Legionella: State of the Art 30 Years After its Recognition. Cianciotto NP, Kwaik YA, Edelstein PH et al. (Eds). ASM Press, Washington, DC, USA 43-50 (2006).
74. Edelstein PH, Hu B, Edelstein MAC. In vitro and intracellular activities of LBM415 (NVP PDF-713) against Legionella pneumophila. Antimicrob. Agents Chemother. 49, 2533-2535 (2005).
75. Hammerschlag MR, Sharma R. Use of cethromycin, a new ketolide, for the treatment of community-acquired respiratory infections. Expert Opin. Investig. Drugs 17, 387-400 (2008).
76. Jung R, Danziger LH, Pendland SL. Intracellular activity of ABT-773 and other antimicrobial agents against Legionella pneumophila. J. Antimicrob. Chemother. 49, 857-861 (2002).
77. Plouffe JF, Herbert MT, File TM et al. Ofloxacin versus standard therapy in treatment of community-acquired pneumonia requiring hospitalization. Antimicrob. Agents Chemother. 40, 1175-1179 (1996).
78. Mertens JC, van Barneveld PWC, Asin HRG et al. Double-blind randomized study comparing the efficacies and safeties of a short (3-day) course of azithromycin and a 5-day course of amoxicillin in patients with acute exacerbations of chronic bronchitis. Antimicrob. Agents Chemother. 36, 1456-1459 (1992).
79. File TM, Segreti J, Dunbar L et al. A multicenter, randomized study comparing the efficacy and sfety of intravenous and/or oral levofloxacin versus ceftriaxona and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia. Antimicrob. Agents Chemother. 41, 1965-1972 (1997).
80. The Nordic Atypical Pneumonia Study Group. Atypical pneumonia in the Nordic countries: aetiology and clinical results of a trial comparing fleroxacin and doxycycline. J. Antimicrob. Chemother. 39, 499-508 (1997).
81. Yu VL, Greenber RN, Zadeikis N et al. Levofloxacin efficacy in the treatment of community-acquired legionellosis. Chest 125, 2135-2139 (2004).
82. Plouffe JF, Breiman RF, Fields BS et al. Azithromycin in the treatment of Legionella pneumonia requiring hospitalization. Clin. Infect. Dis. 37, 1475-1480 (2003).
83. Granowitz EV, Brown RB. Macrolides in community-acquired pneumonia. Does the bell toll for thee? Chest 128, 1089-1092 (2005).
84. Howden BP, Stuart RL, Tallis G, Bailey M, Johneson PDR. Treatment and outcome of 104 hospitalized patients with Legionnaires' disease. Intern. Med. J. 33, 484-488 (2003).
85. Garrido RMB, Parra FJE, Francés LA et al. Antimicrobial chemotherapy for Legionnaires disease: levofloxacin versus macrolides. Clin. Infect. Dis. 40, 800-806 (2005).
86. Sabriá M, Pedro-Botet ML, Gómez J et al. Fluoroquinolones vs macrolides in the treatment of Legionnaires disease. Chest 128, 1401-1405 (2005).
87. Falcó V, Molina I, Juste C et al. Tratamiento de la neumonía por Legionella pneumophila. ¿Macrolidos o quinolonas? Enferm. Infecc. Microbiol. Clin. 24, 360-364 (2006).
88. Grau S, Antonio JM, Ribs E, Salvado M, Garcés JM, Garau J. Impact of rifampicin addition to clarithromycin in Legionella pneumophila pneumonia. Int. J. Antimicrob. Agents 28, 249-252 (2006).
89. Haranaga S, Tateyama M, Higa F et al. Intravenous ciprofloxacin versus erythromycin in the treatment of Legionella pneumonia. Intern. Med. 46, 353-357 (2007).